| PDF - Published Version (331kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-409072
- DOI to cite this document:
- 10.5283/epub.40907
Abstract
Nonalcoholic fatty liver disease (NAFLD) starts with hepatic steatosis, which can progress with inflammation to nonalcoholic steatohepatitis, and a subset of patients develop progressive fibrosis and ultimately cirrhosis. In the majority of cases, NAFLD is associated with (components of) the metabolic syndrome. Obesity, diabetes and hepatic steatosis are also independent risk factors for hepatic ...
Owner only: item control page